These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy. Ferrie CD; Panayiotopoulos CP Seizure; 1994 Jun; 3(2):157-9. PubMed ID: 8081644 [TBL] [Abstract][Full Text] [Related]
25. Reversible aphasic disorder induced by lamotrigine in atypical benign childhood epilepsy. Battaglia D; Iuvone L; Stefanini MC; Acquafondata C; Lettori D; Chiricozzi F; Pane M; Mittica A; Guzzetta F Epileptic Disord; 2001 Dec; 3(4):217-22. PubMed ID: 11844717 [TBL] [Abstract][Full Text] [Related]
26. A survey of lamotrigine and vigabatrin treatment in children with severe epilepsy. Schapel GJ; Wallace SJ; Gordon GS Seizure; 1997 Dec; 6(6):479-83. PubMed ID: 9530945 [TBL] [Abstract][Full Text] [Related]
27. Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study. Coppola G; Auricchio G; Federico R; Carotenuto M; Pascotto A Epilepsia; 2004 Sep; 45(9):1049-53. PubMed ID: 15329068 [TBL] [Abstract][Full Text] [Related]
29. Antiepileptic drugs in development: prospects for the near future. Leppik IE Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517 [TBL] [Abstract][Full Text] [Related]
30. The use of lamotrigine in juvenile myoclonic epilepsy. Buchanan N Seizure; 1996 Jun; 5(2):149-51. PubMed ID: 8795132 [TBL] [Abstract][Full Text] [Related]
31. Levetiracetam-induced myoclonic status epilepticus in myoclonic-astatic epilepsy: a case report. Kröll-Seger J; Mothersill IW; Novak S; Sälke-Kellermann RA; Krämer G Epileptic Disord; 2006 Sep; 8(3):213-8. PubMed ID: 16987744 [TBL] [Abstract][Full Text] [Related]
32. Paradoxic reaction to lamotrigine in a child with benign focal epilepsy of childhood with centrotemporal spikes. Catania S; Cross H; de Sousa C; Boyd S Epilepsia; 1999 Nov; 40(11):1657-60. PubMed ID: 10565596 [TBL] [Abstract][Full Text] [Related]
33. Lamotrigine: clinical experience in 93 patients with epilepsy. Buchanan N Acta Neurol Scand; 1995 Jul; 92(1):28-32. PubMed ID: 7572057 [TBL] [Abstract][Full Text] [Related]
34. Generalized myoclonus and spasticity induced by lamotrigine toxicity: a case report and literature review. Algahtani HA; Aldarmahi AA; Al-Rabia MW; Almalki WH; Bryan Young G Clin Neuropharmacol; 2014; 37(2):52-4. PubMed ID: 24614666 [TBL] [Abstract][Full Text] [Related]
35. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital]. Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941 [TBL] [Abstract][Full Text] [Related]
37. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic]. Vogt H; Krämer G Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401 [TBL] [Abstract][Full Text] [Related]